Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Tapia

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Plos One|April 17, 2018
Supply-side interventions to improve health: Findings from the Salud Mesoamérica InitiativeAli H Mokdad, Erin B Palmisano, Paola Zúñiga-Brenes, et al.
Lancet Regional Health. Americas|April 17, 2025
Type 2 diabetes and cause-specific mortality in Mexico City: a Mendelian randomisation analysisFiona Bragg, Pablo Kuri-Morales, Eirini Trichia, et al.
The Lancet. Public Health|August 26, 2023
Educational and social inequalities and cause-specific mortality in Mexico City: a prospective studyThomas Addey, Jesus Alegre-Díaz, Fiona Bragg, et al.
Diabetes Care|March 27, 2026
Metabolomic Profile of Genetic Liability to Type 2 Diabetes Among 125,000 Mexican Adults: A Mendelian Randomization StudyFiona Bragg, Jesus Alegre-Diaz, Eirini Trichia, et al.
Lancet Regional Health. Americas|February 24, 2026
External validation and recalibration of cardiovascular risk scores for prediction of 10-year risk of fatal cardiovascular disease: a prospective, observational, population-based cohort analysis of adults in Mexico CityJerónimo Perezalonso-Espinosa, Daniel Ramírez-García, Juan Pablo Díaz-Sánchez, et al.
Medrxiv : the Preprint Server for Health Sciences|September 18, 2025
External validation and recalibration of office- and laboratory-based cardiovascular risk scores for prediction of 10-year risk of fatal cardiovascular disease in 112,262 adults in Mexico CityJerónimo Perezalonso-Espinosa, Daniel Ramírez-García, Juan Pablo Díaz-Sánchez, et al.
Emerging Infectious Diseases|January 21, 2003
The U.S.-Mexico Border Infectious Disease Surveillance project: establishing bi-national border surveillanceMichelle Weinberg, Stephen Waterman, Carlos Alvarez Lucas, et al.
Therapeutic Advances in Infectious Disease|September 9, 2021
High-flow nasal cannula therapy for hypoxemic respiratory failure in patients with COVID-19Adrian Palacios Chavarria, Erika Salinas Lezama, Mauricio Gonzalez Navarro, et al.
International Journal of Epidemiology|July 12, 2025
A Mendelian randomization study of the effect of body mass index on 52 causes of death among 125 000 Mexican adults with admixed ancestryLouisa Gnatiuc Friedrichs, Pablo Kuri-Morales, Eirini Trichia, et al.
BMC Public Health|September 2, 2024
Smoking, all-cause, and cause-specific mortality in individuals with diabetes in Mexico: an analysis of the Mexico city prospective studyDaniel Ramírez-García, Carlos A Fermín-Martínez, Paulina Sánchez-Castro, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Plos One|April 17, 2018
Supply-side interventions to improve health: Findings from the Salud Mesoamérica InitiativeAli H Mokdad, Erin B Palmisano, Paola Zúñiga-Brenes, et al.
Lancet Regional Health. Americas|April 17, 2025
Type 2 diabetes and cause-specific mortality in Mexico City: a Mendelian randomisation analysisFiona Bragg, Pablo Kuri-Morales, Eirini Trichia, et al.
The Lancet. Public Health|August 26, 2023
Educational and social inequalities and cause-specific mortality in Mexico City: a prospective studyThomas Addey, Jesus Alegre-Díaz, Fiona Bragg, et al.
Diabetes Care|March 27, 2026
Metabolomic Profile of Genetic Liability to Type 2 Diabetes Among 125,000 Mexican Adults: A Mendelian Randomization StudyFiona Bragg, Jesus Alegre-Diaz, Eirini Trichia, et al.
Lancet Regional Health. Americas|February 24, 2026
External validation and recalibration of cardiovascular risk scores for prediction of 10-year risk of fatal cardiovascular disease: a prospective, observational, population-based cohort analysis of adults in Mexico CityJerónimo Perezalonso-Espinosa, Daniel Ramírez-García, Juan Pablo Díaz-Sánchez, et al.
Medrxiv : the Preprint Server for Health Sciences|September 18, 2025
External validation and recalibration of office- and laboratory-based cardiovascular risk scores for prediction of 10-year risk of fatal cardiovascular disease in 112,262 adults in Mexico CityJerónimo Perezalonso-Espinosa, Daniel Ramírez-García, Juan Pablo Díaz-Sánchez, et al.
Emerging Infectious Diseases|January 21, 2003
The U.S.-Mexico Border Infectious Disease Surveillance project: establishing bi-national border surveillanceMichelle Weinberg, Stephen Waterman, Carlos Alvarez Lucas, et al.
Therapeutic Advances in Infectious Disease|September 9, 2021
High-flow nasal cannula therapy for hypoxemic respiratory failure in patients with COVID-19Adrian Palacios Chavarria, Erika Salinas Lezama, Mauricio Gonzalez Navarro, et al.
International Journal of Epidemiology|July 12, 2025
A Mendelian randomization study of the effect of body mass index on 52 causes of death among 125 000 Mexican adults with admixed ancestryLouisa Gnatiuc Friedrichs, Pablo Kuri-Morales, Eirini Trichia, et al.
BMC Public Health|September 2, 2024
Smoking, all-cause, and cause-specific mortality in individuals with diabetes in Mexico: an analysis of the Mexico city prospective studyDaniel Ramírez-García, Carlos A Fermín-Martínez, Paulina Sánchez-Castro, et al.
Pageof 14